Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-25-000106

Director sold 200 shares at $40.00 ($8,000)

  • Director acquired 200 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Scadden David · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-09-30 Exercise or conversion : show line 1 in the form 10b5-1 +200 $18.09 $3,618 17,803 D
2025-09-30 Sale : show line 2 in the form 10b5-1 −200 $40.00 $8,000 17,603 D
Open-market sales · 200 sh · avg $40.00 · $8,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-09-30 Exercise or conversion : show line 3 in the form 10b5-1 Stock options (right to buy) −200 27,307 D
Loading xslF345X05/wk-form4_1759435431.xml…